The Enterprise Value as of December 2025 (TTM) for Great Novel Therapeutics Biotech & Medicals (7427.TWO) is 1.30B

According to Great Novel Therapeutics Biotech & Medicals’s latest financial reports and current stock price. The company's current Enterprise Value is 1.30B. This represents a change of -22.15% compared to the average of 1.67B of the last 4 quarters.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) Historical Enterprise Value (quarterly & annually)

How has 7427.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Great Novel Therapeutics Biotech & Medicals over the last ten years is 1.18B. The current 1.30B Enterprise Value has changed 10.92% with respect to the historical average. Over the past ten years (40 quarters), 7427.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 3.21B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Great Novel Therapeutics Biotech & Medicals Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) Average Enterprise Value

How has 7427.TWO Enterprise Value performed in the past?

The current Enterprise Value of Great Novel Therapeutics Biotech & Medicals (7427.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Great Novel Therapeutics Biotech & Medicals (7427.TWO) Enterprise Value vs. Peers

How is 7427.TWO’s Enterprise Value compared to its peers?

Great Novel Therapeutics Biotech & Medicals’s Enterprise Value is greater than GeneReach Biotechnology Corp. (1.19B), greater than MegaPro Biomedical Co., Ltd (963.64M), greater than NaviFUS Corp. (1.28B), less than Enimmune corporation (1.36B), less than Lukas Biomedical Inc. (1.42B), greater than Bio Preventive Medicine Corp. (944.05M), greater than LabTurbo Biotech Corporation (711.50M), less than BiOptic Inc. (1.33B), less than NeoCore Technology Co., Ltd. (1.54B), greater than NatureWise Biotech & Medicals Corporation (912.58M),

Build a custom stock screener for Great Novel Therapeutics Biotech & Medicals (7427.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Great Novel Therapeutics Biotech & Medicals using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Great Novel Therapeutics Biotech & Medicals (7427.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Great Novel Therapeutics Biotech & Medicals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.